BIGG

The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy

Nguyen, GC; Seow, CH; Maxwell, C; Huang, V; Leung, Y; Jones, J; Leontiadis, GI; Tse, F; Mahadevan, U; van der Woude, CJ.

Gastroenterology; 150 (3), 2016

"BACKGROUND & AIMS: The management of inflammatory bowel disease (IBD) poses a particular challenge during pregnancy because the health of both the mother and the fetus must be considered. METHODS: A systematic literature search identified studies on the management of IBD during pregnancy. The quality o...

Inmunosupresores/administración & dosificación, Colitis Ulcerosa, Enfermedad de Crohn, Sustitución de Medicamentos, Gastroenterología, Servicios de Salud Materna, Atención Preconceptiva, Complicaciones del Embarazo, Medición de Riesgo, Factores de Riesgo, Resultado del Tratamiento, Enfermedades Inflamatorias del Intestino, Enfermedad de Crohn/diagnóstico, Enfermedad de Crohn/terapia, Complicaciones del Embarazo/diagnóstico, Complicaciones del Embarazo/terapia, Inmunosupresores/efectos adversos, Colitis Ulcerosa/diagnóstico, Colitis Ulcerosa/terapia

Texto completo

The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents: interim policy guidance

The specific objectives were to evaluate the harms to benefits ratio of delamanid in combination with the currently recommended MDR-TB treatment regimen in children. Based on this evaluation, to develop recommendations on the use of delamanid as part of WHO-recommended longer MDR-TB treatment regimens, a...